Evidence map›Paper›PMID 40586577›Full record

ArticleJournal of virology2025

Impact of the changes in substrate specificity of herpes simplex virus 1 protein kinase Us3 on viral infection

Saori Shio, Akihisa Kato, Jurika Kawasaki, Kousuke Takeshima, Yuhei Maruzuru, Naoto Koyanagi, Hayato Harima, Yasushi Kawaguchi

Abstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Saori Shio *Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.ORCID 0009-0002-8884-121X
Akihisa Kato *Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Jurika KawasakiDivision of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Kousuke TakeshimaDivision of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Yuhei MaruzuruDivision of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Naoto KoyanagiDivision of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Hayato HarimaLaboratory of Veterinary Public Health, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Fuchu, Tokyo, Japan.
Yasushi KawaguchiDivision of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.ORCID 0000-0001-8232-6925

Funding

Cell Science Research FoundationGrant for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Science, Sports and technology of Japan 22H04803Grant for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Science, Sports and Technology of Japan 21H00338Grant for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Science, Sports and Technology of Japan 21H00417Grant for Transformative Research Areas from the Ministry of Education, Culture, Science, Sports and Technology of Japan 22H05584Grants for Scientific Research and Grant-in-Aid for Scientific Research (S) from the Japan Society for Promotion of Science (JSPS) 20H05692International Joint Research Project of he Institute of Medical Science, the University of TokyoJapan Agency for Medical Research and Development JP20wm0125002 JP22fk0108640 JP22gm1610008 JP223fa627001 JP23wm0225031 JP23wm0225035Japan Science and Technology Agency JPMJPR22R5Mitsubishi FoundationMSD Life Science FoundationTakeda Science FoundationUehara Memorial Foundation
6 · The paper itself

Abstract

A serine-threonine protein kinase (PK), Us3, encoded by herpes simplex virus 1 (HSV-1), shares substrate specificity with host cellular PKs, protein kinase A (PKA), and AKT. Many Us3 substrates have been identified, and it is thought that during HSV-1 infection, Us3 fine-tunes the phosphorylation levels of individual substrates within their repertoire. However, the significance of this regulatory fine-tuning by Us3 during HSV-1 infection is poorly understood. Here, we found alanine at position 326 (Ala-326) in Us3 was required for the proper fine-tuning of Us3-mediated phosphorylation across the target repertoire in HSV-1-infected cells. Using recombinant viruses in which Us3 Ala-326 was replaced with valine (A326V) or isoleucine (A326I), we showed these mutations selectively altered the phosphorylation of only a subset of at least 14 Us3 target proteins tested in HSV-1-infected cells, with each mutation generally affecting different targets. Of note, (i) both mutations significantly reduced plaque sizes without affecting viral replication in cell cultures; (ii) the Us3 A326I mutation impaired viral replication in the brains of mice and improved survival following intracranial infection, whereas the Us3 A326V mutation had little effect; and (iii) the Us3 A326V mutation reduced ocular pathogenic manifestations and viral replication in the trigeminal ganglia and brains of mice, thereby improving survival following ocular infection. Taken together, these results suggest that the proper fine-tuning of Us3-mediated phosphorylation across its target repertoire is required for efficient cell-to-cell spread of HSV-1

Indexed as

Herpes SimplexHerpesvirus 1, HumanProtein Serine-Threonine KinasesViral ProteinsAnimalsCell LineChlorocebus aethiopsFemaleHumansMiceMutationPhosphorylationSubstrate SpecificityVero CellsVirus ReplicationProtein Serine-Threonine KinasesUS3 protein, Human herpesvirus 1Viral Proteinsactivation loopHSV-1pathogenicityphosphorylation integrityprotein kinaseUs3

Identifiers

PMID40586577
PMCPMC12282182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.